Status:
COMPLETED
Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye
Lead Sponsor:
Hospital Governador Celso Ramos
Conditions:
Blind Painful Eye
Refractory Glaucoma
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes.
Detailed Description
The management of chronic eye pain is a constant challenge to ophthalmology. Treatment varies with the intensity of pain, and topical eye drops and contact lens therapy are effective in many patients....
Eligibility Criteria
Inclusion
- patients treated in the period at HGCR who wanted to be part of the protocol by signing the consent form
Exclusion
- patients whose follow-up period was less than three months
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01404364
Start Date
January 1 2010
End Date
December 1 2010
Last Update
July 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Governador Celso Ramos
Florianópolis, Santa Catarina, Brazil, 88015270